Bavarian Nordic A/S (BVNRY)
11.34
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Bavarian Nordic SG&A Expense (TTM) : 218.74M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 218.74M |
| March 31, 2026 | 207.02M |
| December 31, 2025 | 194.31M |
| September 30, 2025 | 186.98M |
| June 30, 2025 | 154.59M |
| March 31, 2025 | 151.95M |
| December 31, 2024 | 147.16M |
| September 30, 2024 | 135.21M |
| June 30, 2024 | 132.91M |
| March 31, 2024 | 134.60M |
| December 31, 2023 | 126.64M |
| September 30, 2023 | 117.75M |
| June 30, 2023 | 105.23M |
| March 31, 2023 | 88.02M |
| December 31, 2022 | 82.92M |
| September 30, 2022 | 73.93M |
| June 30, 2022 | 73.10M |
| March 31, 2022 | 74.45M |
| December 31, 2021 | 77.13M |
| September 30, 2021 | 80.75M |
| June 30, 2021 | 86.78M |
| March 31, 2021 | 87.80M |
| December 31, 2020 | 86.38M |
| September 30, 2020 | 73.45M |
| June 30, 2020 | 58.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 45.03M |
| December 31, 2019 | 33.99M |
| September 30, 2019 | 32.78M |
| June 30, 2019 | 32.20M |
| March 31, 2019 | 33.42M |
| December 31, 2018 | 33.83M |
| September 30, 2018 | 34.73M |
| June 30, 2018 | 33.85M |
| March 31, 2018 | 32.65M |
| December 31, 2017 | 31.88M |
| September 30, 2017 | 30.66M |
| June 30, 2017 | 31.39M |
| March 31, 2017 | 31.13M |
| December 31, 2016 | 31.60M |
| September 30, 2016 | 32.10M |
| June 30, 2016 | 30.42M |
| March 31, 2016 | 30.28M |
| December 31, 2015 | 32.28M |
| September 30, 2015 | 35.54M |
| June 30, 2015 | 39.44M |
| March 31, 2015 | 40.83M |
| December 31, 2014 | 40.08M |
| September 30, 2014 | 39.29M |
| June 30, 2014 | 37.59M |
| March 31, 2014 | 36.45M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Evaxion AS | 4.527M |
| Genmab A/S | 726.50M |
| Ascendis Pharma A/S | 662.10M |
| Zealand Pharma A/S | 78.53M |
| Agenus, Inc. | 38.48M |